ReP USP - Resultado da busca

Artigo de periodico
Exploring ubiquinone biosynthesis inhibition as a strategy for improving atovaquone efficacy in Malaria (2021)
Verdaguer, Ignasi Bofill; Alba, Camila Andrea Zafra ; Sussmann, R. A. C.; Zuluaga, Norma Lucía Buriticá ; Melo, H. R.; Azevedo, M. F.; Almeida, F. G.; Kimura, Emilia Akemi Shiraishi; Katzin, Alejandro Miguel
Source: Antimicrobial Agents and Chemotherapy. Unidade: ICB
Subjects: PARASITOLOGIA, MALÁRIA, ANTIMALÁRICOS, PLASMODIUM FALCIPARUM, OXIGÊNIO, ANIMAIS PARASITOS, MEDICAMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VERDAGUER, Ignasi Bofill; ALBA, Camila Andrea Zafra; SUSSMANN, R. A. C.; et al. Exploring ubiquinone biosynthesis inhibition as a strategy for improving atovaquone efficacy in Malaria. Antimicrobial Agents and Chemotherapy, Washington, v. 65, n. 4, p. 1-19, 2021. Disponível em: < https://doi.org/10 .1128/AAC.01516-20 > DOI: 10 .1128/AAC.01516-20.
APA
Verdaguer, I. B., Alba, C. A. Z., Sussmann, R. A. C., Zuluaga, N. L. B., Melo, H. R., Azevedo, M. F., et al. (2021). Exploring ubiquinone biosynthesis inhibition as a strategy for improving atovaquone efficacy in Malaria. Antimicrobial Agents and Chemotherapy, 65( 4), 1-19. doi:10 .1128/AAC.01516-20
NLM
Verdaguer IB, Alba CAZ, Sussmann RAC, Zuluaga NLB, Melo HR, Azevedo MF, Almeida FG, Kimura EAS, Katzin AM. Exploring ubiquinone biosynthesis inhibition as a strategy for improving atovaquone efficacy in Malaria [Internet]. Antimicrobial Agents and Chemotherapy. 2021 ; 65( 4): 1-19.Available from: https://doi.org/10 .1128/AAC.01516-20
Vancouver
Verdaguer IB, Alba CAZ, Sussmann RAC, Zuluaga NLB, Melo HR, Azevedo MF, Almeida FG, Kimura EAS, Katzin AM. Exploring ubiquinone biosynthesis inhibition as a strategy for improving atovaquone efficacy in Malaria [Internet]. Antimicrobial Agents and Chemotherapy. 2021 ; 65( 4): 1-19.Available from: https://doi.org/10 .1128/AAC.01516-20
Artigo de periodico
Perillyl alcohol reduces parasite sequestration and cerebrovascular dysfunction during experimental cerebral malaria (2021)
Rodriguez, Adriana Alejandra Marin; Murillo, Oscar ; Sussmann, Rodrigo Antonio Ceschini ; Ortolan, Luana S. ; Battagello, Daniella Sabino ; Quirino, Thatyane de Castro ; Bittencourt, Jackson Cioni ; Epiphanio, Sabrina ; Katzin, Alejandro Miguel ; Carvalho, Leonardo J. M.
Source: Antimicrobial Agents and Chemotherapy. Unidades: FCF, ICB
Subjects: MALÁRIA, ÁLCOOL, ADJUVANTES IMUNOLÓGICOS, ANATOMIA, PARASITOLOGIA, CAMUNDONGOS, CÉLULAS ENDOTELIAIS, FARMACOCINÉTICA, MACRÓFAGOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RODRIGUEZ, Adriana Alejandra Marin; MURILLO, Oscar; SUSSMANN, Rodrigo Antonio Ceschini; et al. Perillyl alcohol reduces parasite sequestration and cerebrovascular dysfunction during experimental cerebral malaria. Antimicrobial Agents and Chemotherapy, Washington, v. 65, n. 5, p. 1-14, 2021. Disponível em: < http://dx.doi.org/10.1128/AAC.00004-21 > DOI: 10.1128/AAC.00004-21.
APA
Rodriguez, A. A. M., Murillo, O., Sussmann, R. A. C., Ortolan, L. S., Battagello, D. S., Quirino, T. de C., et al. (2021). Perillyl alcohol reduces parasite sequestration and cerebrovascular dysfunction during experimental cerebral malaria. Antimicrobial Agents and Chemotherapy, 65( 5), 1-14. doi:10.1128/AAC.00004-21
NLM
Rodriguez AAM, Murillo O, Sussmann RAC, Ortolan LS, Battagello DS, Quirino T de C, Bittencourt JC, Epiphanio S, Katzin AM, Carvalho LJM. Perillyl alcohol reduces parasite sequestration and cerebrovascular dysfunction during experimental cerebral malaria [Internet]. Antimicrobial Agents and Chemotherapy. 2021 ; 65( 5): 1-14.Available from: http://dx.doi.org/10.1128/AAC.00004-21
Vancouver
Rodriguez AAM, Murillo O, Sussmann RAC, Ortolan LS, Battagello DS, Quirino T de C, Bittencourt JC, Epiphanio S, Katzin AM, Carvalho LJM. Perillyl alcohol reduces parasite sequestration and cerebrovascular dysfunction during experimental cerebral malaria [Internet]. Antimicrobial Agents and Chemotherapy. 2021 ; 65( 5): 1-14.Available from: http://dx.doi.org/10.1128/AAC.00004-21
Artigo de periodico
Novel insights into Plasmodium vivax therapeutic failure: CYP2D6 activity and time of exposure to malaria modulate the risk of recurrence (2020)
Silvino, Ana Carolina Rios; Kano, Flora Satiko ; Costa, Marcelo Azevedo; Fontes, Cor Jesus Fernandes; Soares, Irene da Silva ; Brito, Cristiana Ferreira Alves de; Carvalho, Luzia Helena; Sousa, Taís Nóbrega de
Source: Antimicrobial Agents and Chemotherapy. Unidade: FCF
Subjects: PLASMODIUM, MALÁRIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVINO, Ana Carolina Rios; KANO, Flora Satiko; COSTA, Marcelo Azevedo; et al. Novel insights into Plasmodium vivax therapeutic failure: CYP2D6 activity and time of exposure to malaria modulate the risk of recurrence. Antimicrobial Agents and Chemotherapy, Washington, v. 64, n. 5, p. 1-14 art. e02056-19, 2020. Disponível em: < https://doi.org/10.1128/AAC.02056-19 > DOI: 10.1128/AAC.02056-19.
APA
Silvino, A. C. R., Kano, F. S., Costa, M. A., Fontes, C. J. F., Soares, I. da S., Brito, C. F. A. de, et al. (2020). Novel insights into Plasmodium vivax therapeutic failure: CYP2D6 activity and time of exposure to malaria modulate the risk of recurrence. Antimicrobial Agents and Chemotherapy, 64( 5), 1-14 art. e02056-19. doi:10.1128/AAC.02056-19
NLM
Silvino ACR, Kano FS, Costa MA, Fontes CJF, Soares I da S, Brito CFA de, Carvalho LH, Sousa TN de. Novel insights into Plasmodium vivax therapeutic failure: CYP2D6 activity and time of exposure to malaria modulate the risk of recurrence [Internet]. Antimicrobial Agents and Chemotherapy. 2020 ; 64( 5): 1-14 art. e02056-19.Available from: https://doi.org/10.1128/AAC.02056-19
Vancouver
Silvino ACR, Kano FS, Costa MA, Fontes CJF, Soares I da S, Brito CFA de, Carvalho LH, Sousa TN de. Novel insights into Plasmodium vivax therapeutic failure: CYP2D6 activity and time of exposure to malaria modulate the risk of recurrence [Internet]. Antimicrobial Agents and Chemotherapy. 2020 ; 64( 5): 1-14 art. e02056-19.Available from: https://doi.org/10.1128/AAC.02056-19
Artigo de periodico
Transferable resistance gene optrA in Enterococcus faecalis from swine in Brazil (2020)
Almeida, Lara Mendes de; Nascimento, Ticiano G; Filsner, Pedro Henrique de Lima; Moreno, Andrea Micke ; Gilmore, Michael S; Lebreton, Francois; Gaca, Anthony; Bispo, Paulo M; Saavedra, Jose T; Calumby, Rodrigo N; Grillo, Luciano M
Source: Antimicrobial Agents and Chemotherapy. Unidade: FMVZ
Subjects: SUÍNOS, ENTEROCOCCUS, INFECÇÕES BACTERIANAS GRAM-POSITIVAS, BACTERIOSES EM ANIMAIS, GENÉTICA BACTERIANA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ALMEIDA, Lara Mendes de; NASCIMENTO, Ticiano G; FILSNER, Pedro Henrique de Lima; et al. Transferable resistance gene optrA in Enterococcus faecalis from swine in Brazil. Antimicrobial Agents and Chemotherapy, Washington, v. 64, n. 6, p. 1-11, 2020. Disponível em: < https://doi.org/10.1128/AAC.00142-20 > DOI: 10.1128/AAC.00142-20.
APA
Almeida, L. M. de, Nascimento, T. G., Filsner, P. H. de L., Moreno, A. M., Gilmore, M. S., Lebreton, F., et al. (2020). Transferable resistance gene optrA in Enterococcus faecalis from swine in Brazil. Antimicrobial Agents and Chemotherapy, 64( 6), 1-11. doi:10.1128/AAC.00142-20
NLM
Almeida LM de, Nascimento TG, Filsner PH de L, Moreno AM, Gilmore MS, Lebreton F, Gaca A, Bispo PM, Saavedra JT, Calumby RN, Grillo LM. Transferable resistance gene optrA in Enterococcus faecalis from swine in Brazil [Internet]. Antimicrobial Agents and Chemotherapy. 2020 ; 64( 6): 1-11.Available from: https://doi.org/10.1128/AAC.00142-20
Vancouver
Almeida LM de, Nascimento TG, Filsner PH de L, Moreno AM, Gilmore MS, Lebreton F, Gaca A, Bispo PM, Saavedra JT, Calumby RN, Grillo LM. Transferable resistance gene optrA in Enterococcus faecalis from swine in Brazil [Internet]. Antimicrobial Agents and Chemotherapy. 2020 ; 64( 6): 1-11.Available from: https://doi.org/10.1128/AAC.00142-20
Artigo de periodico
Computational chemogenomics drug repositioning strategy enables the discovery of epirubicin as a new repurposed hit for Plasmodium Falciparum and P. vivax (2020)
Ferreira, Letícia Tiburcio ; Rodrigues, Juliana; Cassiano, Gustavo Capatti ; Tavella, Tatyana Almeida ; Tomaz, Kaira Cristina Peralis; Silva, Djane Clarys Baia da ; Souza, Macejane Ferreira; Lima, Marilia Nunes do Nascimento; Mottin, Melina ; Almeida, Ludimila Dias; Paim, Juliana Calit ; Puça, Maria Carolina Silva de Barros; Melo, Gisely Cardoso; Bargieri, Daniel Youssef ; Lopes, Stefanie Costa Pinto ; Lacerda, Marcus Vinicius Guimarães ; Bilsland, Elizabeth ; Sunnerhagen, Per ; Neves, Bruno Junior ; Andrade, Carolina Horta ; Cravo, Pedro Vitor Lemo ; Costa, Fabio Trindade Maranhão
Source: Antimicrobial Agents and Chemotherapy. Unidade: ICB
Subjects: PARASITOLOGIA, MALÁRIA, ANTIMALÁRICOS, PLASMODIUM FALCIPARUM, MEDICAMENTO, RESISTÊNCIA MICROBIANA ÀS DROGAS, REPLICAÇÃO DO DNA, ATIVAÇÃO ENZIMÁTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERREIRA, Letícia Tiburcio; RODRIGUES, Juliana; CASSIANO, Gustavo Capatti; et al. Computational chemogenomics drug repositioning strategy enables the discovery of epirubicin as a new repurposed hit for Plasmodium Falciparum and P. vivax. Antimicrobial Agents and Chemotherapy, Washington, v. 64, n. 9, p. 16 , 2020. Disponível em: < https://doi .org/10.1128/AAC.02041-19 > DOI: 10.1128/AAC.02041-19.
APA
Ferreira, L. T., Rodrigues, J., Cassiano, G. C., Tavella, T. A., Tomaz, K. C. P., Silva, D. C. B. da, et al. (2020). Computational chemogenomics drug repositioning strategy enables the discovery of epirubicin as a new repurposed hit for Plasmodium Falciparum and P. vivax. Antimicrobial Agents and Chemotherapy, 64( 9), 16 . doi:10.1128/AAC.02041-19
NLM
Ferreira LT, Rodrigues J, Cassiano GC, Tavella TA, Tomaz KCP, Silva DCB da, Souza MF, Lima MN do N, Mottin M, Almeida LD, Paim JC, Puça MCS de B, Melo GC, Bargieri DY, Lopes SCP, Lacerda MVG, Bilsland E, Sunnerhagen P, Neves BJ, Andrade CH, Cravo PVL, Costa FTM. Computational chemogenomics drug repositioning strategy enables the discovery of epirubicin as a new repurposed hit for Plasmodium Falciparum and P. vivax [Internet]. Antimicrobial Agents and Chemotherapy. 2020 ; 64( 9): 16 .Available from: https://doi .org/10.1128/AAC.02041-19
Vancouver
Ferreira LT, Rodrigues J, Cassiano GC, Tavella TA, Tomaz KCP, Silva DCB da, Souza MF, Lima MN do N, Mottin M, Almeida LD, Paim JC, Puça MCS de B, Melo GC, Bargieri DY, Lopes SCP, Lacerda MVG, Bilsland E, Sunnerhagen P, Neves BJ, Andrade CH, Cravo PVL, Costa FTM. Computational chemogenomics drug repositioning strategy enables the discovery of epirubicin as a new repurposed hit for Plasmodium Falciparum and P. vivax [Internet]. Antimicrobial Agents and Chemotherapy. 2020 ; 64( 9): 16 .Available from: https://doi .org/10.1128/AAC.02041-19
Artigo de periodico
A fluorinated phenylbenzothiazole arrests the Trypanosoma cruzi cell cycle and diminishes the infection of mammalian host cells (2020)
Hernández, Roberto Issac Cuevas ; Girard, Richard Marcel Bruno Moreira; Cerón, Sarai Martínez; Silva, Marcelo Santos da ; Elias, Maria Carolina ; Crispim, Marcell ; Ferrara, José G. Trujill ; Silber, Ariel Mariano
Source: Antimicrobial Agents and Chemotherapy. Unidade: ICB
Subjects: PARASITOLOGIA, DOENÇA DE CHAGAS, TRYPANOSOMA CRUZI, INFECÇÕES POR PROTOZOÁRIOS, QUIMIOTERÁPICOS, ANTIPARASITÁRIOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HERNÁNDEZ, Roberto Issac Cuevas; GIRARD, Richard Marcel Bruno Moreira; CERÓN, Sarai Martínez; et al. A fluorinated phenylbenzothiazole arrests the Trypanosoma cruzi cell cycle and diminishes the infection of mammalian host cells. Antimicrobial Agents and Chemotherapy, Washington-DC, v. 64, n. 2, 2020. Disponível em: < https://doi.org/10.1128/AAC.01742-19 > DOI: 10.1128/AAC.01742-19.
APA
Hernández, R. I. C., Girard, R. M. B. M., Cerón, S. M., Silva, M. S. da, Elias, M. C., Crispim, M., et al. (2020). A fluorinated phenylbenzothiazole arrests the Trypanosoma cruzi cell cycle and diminishes the infection of mammalian host cells. Antimicrobial Agents and Chemotherapy, 64( 2). doi:10.1128/AAC.01742-19
NLM
Hernández RIC, Girard RMBM, Cerón SM, Silva MS da, Elias MC, Crispim M, Ferrara JGT, Silber AM. A fluorinated phenylbenzothiazole arrests the Trypanosoma cruzi cell cycle and diminishes the infection of mammalian host cells [Internet]. Antimicrobial Agents and Chemotherapy. 2020 ; 64( 2):Available from: https://doi.org/10.1128/AAC.01742-19
Vancouver
Hernández RIC, Girard RMBM, Cerón SM, Silva MS da, Elias MC, Crispim M, Ferrara JGT, Silber AM. A fluorinated phenylbenzothiazole arrests the Trypanosoma cruzi cell cycle and diminishes the infection of mammalian host cells [Internet]. Antimicrobial Agents and Chemotherapy. 2020 ; 64( 2):Available from: https://doi.org/10.1128/AAC.01742-19
Artigo de periodico
Promethazine Exhibits Antiparasitic Properties In Vitro and Reduces Worm Burden, Egg Production, Hepatomegaly, and Splenomegaly in a Schistosomiasis Animal Model (2019)
Roquini, Daniel B; Cogo, Ramon M; Mengarda, Ana C; Mazloum, Susana F; Morais, Cristiane S; Xavier, Rogério P; Salvadori, Maria Cecília ; Teixeira, Fernanda Sá ; Ferreira, Luiz E; Pinto Pedro L; Morais, Thiago R; Moraes, Josué de
Source: Antimicrobial Agents and Chemotherapy. Unidade: IF
Subjects: ESQUISTOSSOMOSE, MEDICAMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ROQUINI, Daniel B; COGO, Ramon M; MENGARDA, Ana C; et al. Promethazine Exhibits Antiparasitic Properties In Vitro and Reduces Worm Burden, Egg Production, Hepatomegaly, and Splenomegaly in a Schistosomiasis Animal Model. Antimicrobial Agents and Chemotherapy, Washington, DC, v. 63, n. 12, p. 1-10, 2019. Disponível em: < https://doi.org/10.1128/AAC .01208-19 > DOI: 10.1128/AAC.01208-19.
APA
Roquini, D. B., Cogo, R. M., Mengarda, A. C., Mazloum, S. F., Morais, C. S., Xavier, R. P., et al. (2019). Promethazine Exhibits Antiparasitic Properties In Vitro and Reduces Worm Burden, Egg Production, Hepatomegaly, and Splenomegaly in a Schistosomiasis Animal Model. Antimicrobial Agents and Chemotherapy, 63( 12), 1-10. doi:10.1128/AAC.01208-19
NLM
Roquini DB, Cogo RM, Mengarda AC, Mazloum SF, Morais CS, Xavier RP, Salvadori MC, Teixeira FS, Ferreira LE, Pinto Pedro L, Morais TR, Moraes J de. Promethazine Exhibits Antiparasitic Properties In Vitro and Reduces Worm Burden, Egg Production, Hepatomegaly, and Splenomegaly in a Schistosomiasis Animal Model [Internet]. Antimicrobial Agents and Chemotherapy. 2019 ; 63( 12): 1-10.Available from: https://doi.org/10.1128/AAC .01208-19
Vancouver
Roquini DB, Cogo RM, Mengarda AC, Mazloum SF, Morais CS, Xavier RP, Salvadori MC, Teixeira FS, Ferreira LE, Pinto Pedro L, Morais TR, Moraes J de. Promethazine Exhibits Antiparasitic Properties In Vitro and Reduces Worm Burden, Egg Production, Hepatomegaly, and Splenomegaly in a Schistosomiasis Animal Model [Internet]. Antimicrobial Agents and Chemotherapy. 2019 ; 63( 12): 1-10.Available from: https://doi.org/10.1128/AAC .01208-19
Artigo de periodico
Daptomycin resistance and tolerance due to loss of function in Staphylococcus aureus dsp1 and asp23 (2019)
Barros, Elaine M; Martin, Melissa J; Selleck, Elizabeth M; Lebreton, Francois; Sampaio, Jorge Luiz Mello ; Gilmore, Michael S
Source: Antimicrobial Agents and Chemotherapy. Unidade: FCF
Subjects: STAPHYLOCOCCUS, ANTIBIÓTICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BARROS, Elaine M; MARTIN, Melissa J; SELLECK, Elizabeth M; et al. Daptomycin resistance and tolerance due to loss of function in Staphylococcus aureus dsp1 and asp23. Antimicrobial Agents and Chemotherapy, Washington, v. 63, n. 1, p. 1-12 art. e01542-18, 2019. Disponível em: < http://dx.doi.org/10.1128/AAC.01542-18 > DOI: 10.1128/AAC.01542-18.
APA
Barros, E. M., Martin, M. J., Selleck, E. M., Lebreton, F., Sampaio, J. L. M., & Gilmore, M. S. (2019). Daptomycin resistance and tolerance due to loss of function in Staphylococcus aureus dsp1 and asp23. Antimicrobial Agents and Chemotherapy, 63( 1), 1-12 art. e01542-18. doi:10.1128/AAC.01542-18
NLM
Barros EM, Martin MJ, Selleck EM, Lebreton F, Sampaio JLM, Gilmore MS. Daptomycin resistance and tolerance due to loss of function in Staphylococcus aureus dsp1 and asp23 [Internet]. Antimicrobial Agents and Chemotherapy. 2019 ; 63( 1): 1-12 art. e01542-18.Available from: http://dx.doi.org/10.1128/AAC.01542-18
Vancouver
Barros EM, Martin MJ, Selleck EM, Lebreton F, Sampaio JLM, Gilmore MS. Daptomycin resistance and tolerance due to loss of function in Staphylococcus aureus dsp1 and asp23 [Internet]. Antimicrobial Agents and Chemotherapy. 2019 ; 63( 1): 1-12 art. e01542-18.Available from: http://dx.doi.org/10.1128/AAC.01542-18
Artigo de periodico
Early dissemination of qnrE1 in Salmonella enterica serovar typhimurium from livestock in south america (2019)
Monte, Daniel Farias Marinho do ; Lincopan, Nilton ; Cerdeira, Louise ; Cray, Paula J Fedorka; Landgraf, Mariza
Source: Antimicrobial Agents and Chemotherapy. Unidade: FCF
Subjects: SALMONELLA, MICROBIOLOGIA DE ALIMENTOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MONTE, Daniel Farias Marinho do; LINCOPAN, Nilton; CERDEIRA, Louise; CRAY, Paula J Fedorka; LANDGRAF, Mariza. Early dissemination of qnrE1 in Salmonella enterica serovar typhimurium from livestock in south america. Antimicrobial Agents and Chemotherapy, Washington, v. 63, n. 9, p. 1-3 art. e00571-19, 2019. Disponível em: < http://dx.doi.org/10.1128/AAC.00571-19 > DOI: 10.1128/AAC.00571-19.
APA
Monte, D. F. M. do, Lincopan, N., Cerdeira, L., Cray, P. J. F., & Landgraf, M. (2019). Early dissemination of qnrE1 in Salmonella enterica serovar typhimurium from livestock in south america. Antimicrobial Agents and Chemotherapy, 63( 9), 1-3 art. e00571-19. doi:10.1128/AAC.00571-19
NLM
Monte DFM do, Lincopan N, Cerdeira L, Cray PJF, Landgraf M. Early dissemination of qnrE1 in Salmonella enterica serovar typhimurium from livestock in south america [Internet]. Antimicrobial Agents and Chemotherapy. 2019 ; 63( 9): 1-3 art. e00571-19.Available from: http://dx.doi.org/10.1128/AAC.00571-19
Vancouver
Monte DFM do, Lincopan N, Cerdeira L, Cray PJF, Landgraf M. Early dissemination of qnrE1 in Salmonella enterica serovar typhimurium from livestock in south america [Internet]. Antimicrobial Agents and Chemotherapy. 2019 ; 63( 9): 1-3 art. e00571-19.Available from: http://dx.doi.org/10.1128/AAC.00571-19
Artigo de periodico
Decyl Gallate as a possible inhibitor of N-Glycosylation process in Paracoccidioides lutzii (2019)
Silva, Ana Carolina Alves de Paula e ; Oliveira, Haroldo Cesar de ; Scorzoni, Liliana ; Marcos, Caroline Maria ; Santos, Cláudia Tavares dos; Almeida, Ana Marisa Fusco; Salina, Ana Carolina Guerta ; Medeiros, Alexandra Ivo ; Almeida, Fausto Bruno dos Reis ; Li, Sheena Claire; Boone, Charles; Mendes-Giannini, Maria José Soares
Source: Antimicrobial Agents and Chemotherapy. Unidade: FMRP
Subjects: PARACOCCIDIOIDES, ANTIFÚNGICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Ana Carolina Alves de Paula e; OLIVEIRA, Haroldo Cesar de; SCORZONI, Liliana; et al. Decyl Gallate as a possible inhibitor of N-Glycosylation process in Paracoccidioides lutzii. Antimicrobial Agents and Chemotherapy, Washington, v. 63, n. 11, 2019. Disponível em: < http://dx.doi.org/10.1128/aac.01909-18 > DOI: 10.1128/aac.01909-18.
APA
Silva, A. C. A. de P. e, Oliveira, H. C. de, Scorzoni, L., Marcos, C. M., Santos, C. T. dos, Almeida, A. M. F., et al. (2019). Decyl Gallate as a possible inhibitor of N-Glycosylation process in Paracoccidioides lutzii. Antimicrobial Agents and Chemotherapy, 63( 11). doi:10.1128/aac.01909-18
NLM
Silva ACA de P e, Oliveira HC de, Scorzoni L, Marcos CM, Santos CT dos, Almeida AMF, Salina ACG, Medeiros AI, Almeida FB dos R, Li SC, Boone C, Mendes-Giannini MJS. Decyl Gallate as a possible inhibitor of N-Glycosylation process in Paracoccidioides lutzii [Internet]. Antimicrobial Agents and Chemotherapy. 2019 ; 63( 11):Available from: http://dx.doi.org/10.1128/aac.01909-18
Vancouver
Silva ACA de P e, Oliveira HC de, Scorzoni L, Marcos CM, Santos CT dos, Almeida AMF, Salina ACG, Medeiros AI, Almeida FB dos R, Li SC, Boone C, Mendes-Giannini MJS. Decyl Gallate as a possible inhibitor of N-Glycosylation process in Paracoccidioides lutzii [Internet]. Antimicrobial Agents and Chemotherapy. 2019 ; 63( 11):Available from: http://dx.doi.org/10.1128/aac.01909-18
Artigo de periodico
In vitro and in vivo studies of spironolactone as an antischistosomal drug capable of clinical repurposing (2019)
Guerra, Rafael A; Oliveira, Rosimeire N de; Rocha, Jefferson, A; Pinto, Pedro L S; Moraes, Josué de; Silva, Marcos P; Silva, Tais C; Salvadori, Maria Cecília Barbosa da Silveira; Teixeira, Fernanda Sá
Source: Antimicrobial Agents and Chemotherapy. Unidade: IF
Assunto: ESQUISTOSSOMOSE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GUERRA, Rafael A; OLIVEIRA, Rosimeire N de; ROCHA, Jefferson; et al. In vitro and in vivo studies of spironolactone as an antischistosomal drug capable of clinical repurposing. Antimicrobial Agents and Chemotherapy, Washington, v. 63, n. 3, p. 1-11, 2019. DOI: 10.1128/AAC.01722-18.
APA
Guerra, R. A., Oliveira, R. N. de, Rocha, J., Pinto, P. L. S., Moraes, J. de, Silva, M. P., et al. (2019). In vitro and in vivo studies of spironolactone as an antischistosomal drug capable of clinical repurposing. Antimicrobial Agents and Chemotherapy, 63( 3), 1-11. doi:10.1128/AAC.01722-18
NLM
Guerra RA, Oliveira RN de, Rocha J, Pinto PLS, Moraes J de, Silva MP, Silva TC, Salvadori MCB da S, Teixeira FS. In vitro and in vivo studies of spironolactone as an antischistosomal drug capable of clinical repurposing. Antimicrobial Agents and Chemotherapy. 2019 ; 63( 3): 1-11.
Vancouver
Guerra RA, Oliveira RN de, Rocha J, Pinto PLS, Moraes J de, Silva MP, Silva TC, Salvadori MCB da S, Teixeira FS. In vitro and in vivo studies of spironolactone as an antischistosomal drug capable of clinical repurposing. Antimicrobial Agents and Chemotherapy. 2019 ; 63( 3): 1-11.
Artigo de periodico-carta/editorial
Plasmid carrying bla CTX-M-2 and bla GES-1 in extensively drug-resistant Pseudomonas aeruginosa from cerebrospinal fluid. [Carta] (2019)
Ballaben, Anelise Stella ; Galetti, Renata; Andrade, Leonardo Neves de ; Ferreira, Joseane Cristina; Garcia, Doroti de Oliveira ; Silva, Paulo da; Doi, Yohei; Darini, Ana Lúcia da Costa
Source: Antimicrobial Agents and Chemotherapy. Unidade: FCFRP
Subjects: LÍQUIDO CEFALORRAQUIDIANO, ELETROFORESE, TESTES DE SENSIBILIDADE MICROBIANA, PSEUDOMONAS, PLASMÍDEOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BALLABEN, Anelise Stella; GALETTI, Renata; ANDRADE, Leonardo Neves de; et al. Plasmid carrying bla CTX-M-2 and bla GES-1 in extensively drug-resistant Pseudomonas aeruginosa from cerebrospinal fluid. [Carta]. Antimicrobial Agents and Chemotherapy[S.l: s.n.], 2019.Disponível em: DOI: 10.1128/AAC.00186-19.
APA
Ballaben, A. S., Galetti, R., Andrade, L. N. de, Ferreira, J. C., Garcia, D. de O., Silva, P. da, et al. (2019). Plasmid carrying bla CTX-M-2 and bla GES-1 in extensively drug-resistant Pseudomonas aeruginosa from cerebrospinal fluid. [Carta]. Antimicrobial Agents and Chemotherapy. Washington. doi:10.1128/AAC.00186-19
NLM
Ballaben AS, Galetti R, Andrade LN de, Ferreira JC, Garcia D de O, Silva P da, Doi Y, Darini AL da C. Plasmid carrying bla CTX-M-2 and bla GES-1 in extensively drug-resistant Pseudomonas aeruginosa from cerebrospinal fluid. [Carta] [Internet]. Antimicrobial Agents and Chemotherapy. 2019 ; 63( 7): e00186-19.Available from: https://doi.org/10.1128/AAC.00186-19
Vancouver
Ballaben AS, Galetti R, Andrade LN de, Ferreira JC, Garcia D de O, Silva P da, Doi Y, Darini AL da C. Plasmid carrying bla CTX-M-2 and bla GES-1 in extensively drug-resistant Pseudomonas aeruginosa from cerebrospinal fluid. [Carta] [Internet]. Antimicrobial Agents and Chemotherapy. 2019 ; 63( 7): e00186-19.Available from: https://doi.org/10.1128/AAC.00186-19
Artigo de periodico
Screening the pathogen box for molecules active against Plasmodium sexual stages using a new nanoluciferase-based transgenic line of P. berghei identifies transmission-blocking compounds (2018)
Calit, Juliana; Dobrescu, Irina ; Gaitán, Xiomara A.; Borges, Miriam H.; Ramos, Marisé S.; Eastman, Richard T. ; Bargieri, Daniel Youssef
Source: Antimicrobial Agents and Chemotherapy. Unidade: ICB
Subjects: PARASITOLOGIA, PLASMODIUM, TRANSGENES, MALÁRIA, MEDICAMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CALIT, Juliana; DOBRESCU, Irina; GAITÁN, Xiomara A.; et al. Screening the pathogen box for molecules active against Plasmodium sexual stages using a new nanoluciferase-based transgenic line of P. berghei identifies transmission-blocking compounds. Antimicrobial Agents and Chemotherapy, Washington, v. 62, n. 11, p. e01053-18, 2018. Disponível em: < http://dx.doi: 10.1128/AEM.00235-18 > DOI: 10.1128/AAC.01053-18.
APA
Calit, J., Dobrescu, I., Gaitán, X. A., Borges, M. H., Ramos, M. S., Eastman, R. T., & Bargieri, D. Y. (2018). Screening the pathogen box for molecules active against Plasmodium sexual stages using a new nanoluciferase-based transgenic line of P. berghei identifies transmission-blocking compounds. Antimicrobial Agents and Chemotherapy, 62( 11), e01053-18. doi:10.1128/AAC.01053-18
NLM
Calit J, Dobrescu I, Gaitán XA, Borges MH, Ramos MS, Eastman RT, Bargieri DY. Screening the pathogen box for molecules active against Plasmodium sexual stages using a new nanoluciferase-based transgenic line of P. berghei identifies transmission-blocking compounds [Internet]. Antimicrobial Agents and Chemotherapy. 2018 ; 62( 11): e01053-18.Available from: http://dx.doi: 10.1128/AEM.00235-18
Vancouver
Calit J, Dobrescu I, Gaitán XA, Borges MH, Ramos MS, Eastman RT, Bargieri DY. Screening the pathogen box for molecules active against Plasmodium sexual stages using a new nanoluciferase-based transgenic line of P. berghei identifies transmission-blocking compounds [Internet]. Antimicrobial Agents and Chemotherapy. 2018 ; 62( 11): e01053-18.Available from: http://dx.doi: 10.1128/AEM.00235-18
Artigo de periodico
Miltefosine has a postantifungal effect and induces apoptosis in Cryptococcus yeasts (2018)
Spadari, Cristina de Castro ; Vila, Taissa Vieira Machado ; Rozental, Sonia ; Ishida, Kelly
Source: Antimicrobial Agents and Chemotherapy. Unidade: ICB
Subjects: MICROBIOLOGIA, ANTIFÚNGICOS, LEVEDURAS, CRYPTOCOCCUS, APOPTOSE, MITOCÔNDRIAS, FUNGICIDAS, MEMBRANA PLASMÁTICA, MICROSCOPIA ELETRÔNICA, MORFOMETRIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SPADARI, Cristina de Castro; VILA, Taissa Vieira Machado; ROZENTAL, Sonia; ISHIDA, Kelly. Miltefosine has a postantifungal effect and induces apoptosis in Cryptococcus yeasts. Antimicrobial Agents and Chemotherapy, Washington, DC, v. 62, n. 8, 2018. Disponível em: < https://doi.org/10.1128/AAC.00312-18 > DOI: 10.1128/AAC.00312-18.
APA
Spadari, C. de C., Vila, T. V. M., Rozental, S., & Ishida, K. (2018). Miltefosine has a postantifungal effect and induces apoptosis in Cryptococcus yeasts. Antimicrobial Agents and Chemotherapy, 62( 8). doi:10.1128/AAC.00312-18
NLM
Spadari C de C, Vila TVM, Rozental S, Ishida K. Miltefosine has a postantifungal effect and induces apoptosis in Cryptococcus yeasts [Internet]. Antimicrobial Agents and Chemotherapy. 2018 ; 62( 8):Available from: https://doi.org/10.1128/AAC.00312-18
Vancouver
Spadari C de C, Vila TVM, Rozental S, Ishida K. Miltefosine has a postantifungal effect and induces apoptosis in Cryptococcus yeasts [Internet]. Antimicrobial Agents and Chemotherapy. 2018 ; 62( 8):Available from: https://doi.org/10.1128/AAC.00312-18
Artigo de periodico
Metabolism of oxo-bile acids and characterization of recombinant 12α-hydroxysteroid dehydrogenases from bile acid 7α-dehydroxylating human gut bacteria (2018)
Doden, Heidi ; Sallam, Lina A.; Devendran, Saravanan ; Ly, Lindsey; Doden, Greta ; Daniel, Steven L.; Alves, João Marcelo Pereira ; Ridlon, Jason M.
Source: Antimicrobial Agents and Chemotherapy. Unidade: ICB
Subjects: PARASITOLOGIA, ÁCIDOS, METABOLISMO, CLOSTRIDIUM
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DODEN, Heidi; SALLAM, Lina A.; DEVENDRAN, Saravanan; et al. Metabolism of oxo-bile acids and characterization of recombinant 12α-hydroxysteroid dehydrogenases from bile acid 7α-dehydroxylating human gut bacteria. Antimicrobial Agents and Chemotherapy, Washington, v. 84, n. 10, p. e00235-18, 2018. Disponível em: < http://dx.doi.org/10.1128/AEM.00235-18 > DOI: 10.1128/AEM.00235-18.
APA
Doden, H., Sallam, L. A., Devendran, S., Ly, L., Doden, G., Daniel, S. L., et al. (2018). Metabolism of oxo-bile acids and characterization of recombinant 12α-hydroxysteroid dehydrogenases from bile acid 7α-dehydroxylating human gut bacteria. Antimicrobial Agents and Chemotherapy, 84( 10), e00235-18. doi:10.1128/AEM.00235-18
NLM
Doden H, Sallam LA, Devendran S, Ly L, Doden G, Daniel SL, Alves JMP, Ridlon JM. Metabolism of oxo-bile acids and characterization of recombinant 12α-hydroxysteroid dehydrogenases from bile acid 7α-dehydroxylating human gut bacteria [Internet]. Antimicrobial Agents and Chemotherapy. 2018 ; 84( 10): e00235-18.Available from: http://dx.doi.org/10.1128/AEM.00235-18
Vancouver
Doden H, Sallam LA, Devendran S, Ly L, Doden G, Daniel SL, Alves JMP, Ridlon JM. Metabolism of oxo-bile acids and characterization of recombinant 12α-hydroxysteroid dehydrogenases from bile acid 7α-dehydroxylating human gut bacteria [Internet]. Antimicrobial Agents and Chemotherapy. 2018 ; 84( 10): e00235-18.Available from: http://dx.doi.org/10.1128/AEM.00235-18
Artigo de periodico
Genetic and functional characterization of an MCR-3-like producing Escherichia coli recovered from swine, Brazil (2018)
Kieffer, Nicolas; Nordmann, Patrice; Moreno, Andrea Micke; Moreno, Luisa Zanolli; Chaby, Richard; Breton, Aude; Tissières, Pierre; Poirel, Laurent
Source: Antimicrobial Agents and Chemotherapy. Unidade: FMVZ
Subjects: SUÍNOS, ESCHERICHIA COLI, GENÉTICA BACTERIANA, TRANSFERASES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
KIEFFER, Nicolas; NORDMANN, Patrice; MORENO, Andrea Micke; et al. Genetic and functional characterization of an MCR-3-like producing Escherichia coli recovered from swine, Brazil. Antimicrobial Agents and Chemotherapy, Washington, v. 62, n. 7, p. 8 , 2018. Disponível em: < http://dx.doi.org/10.1128/AAC.00278-18 > DOI: 10.1128/AAC.00278-18.
APA
Kieffer, N., Nordmann, P., Moreno, A. M., Moreno, L. Z., Chaby, R., Breton, A., et al. (2018). Genetic and functional characterization of an MCR-3-like producing Escherichia coli recovered from swine, Brazil. Antimicrobial Agents and Chemotherapy, 62( 7), 8 . doi:10.1128/AAC.00278-18
NLM
Kieffer N, Nordmann P, Moreno AM, Moreno LZ, Chaby R, Breton A, Tissières P, Poirel L. Genetic and functional characterization of an MCR-3-like producing Escherichia coli recovered from swine, Brazil [Internet]. Antimicrobial Agents and Chemotherapy. 2018 ; 62( 7): 8 .Available from: http://dx.doi.org/10.1128/AAC.00278-18
Vancouver
Kieffer N, Nordmann P, Moreno AM, Moreno LZ, Chaby R, Breton A, Tissières P, Poirel L. Genetic and functional characterization of an MCR-3-like producing Escherichia coli recovered from swine, Brazil [Internet]. Antimicrobial Agents and Chemotherapy. 2018 ; 62( 7): 8 .Available from: http://dx.doi.org/10.1128/AAC.00278-18
Artigo de periodico
Enhanced ex vivo Plasmodium vivax intraerythrocytic enrichment and maturation for rapid and sensitive parasite growth assays (2018)
Rangel, Gabriel W. ; Clark, Martha A.; Kanjee, Usheer ; Lim, Caeul; Shaw-Saliba, Kathryn; Menezes, Maria José; Mascarenhas, Anjali ; Chery, Laura ; Gomes, Edwin; Rathod, Pradipsinh K. ; Ferreira, Marcelo Urbano ; Duraisingh, Manoj T.
Source: Antimicrobial Agents and Chemotherapy. Unidade: ICB
Subjects: PARASITOLOGIA, PLASMODIUM, MALÁRIA, ANTIMALÁRICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RANGEL, Gabriel W.; CLARK, Martha A.; KANJEE, Usheer; et al. Enhanced ex vivo Plasmodium vivax intraerythrocytic enrichment and maturation for rapid and sensitive parasite growth assays. Antimicrobial Agents and Chemotherapy, Washington, v. 62, n. 4, p. e02519-7, 2018. Disponível em: < http://dx.doi.org/10.1128/AAC.02519-17 > DOI: 10.1128/AAC.02519-17.
APA
Rangel, G. W., Clark, M. A., Kanjee, U., Lim, C., Shaw-Saliba, K., Menezes, M. J., et al. (2018). Enhanced ex vivo Plasmodium vivax intraerythrocytic enrichment and maturation for rapid and sensitive parasite growth assays. Antimicrobial Agents and Chemotherapy, 62( 4), e02519-7. doi:10.1128/AAC.02519-17
NLM
Rangel GW, Clark MA, Kanjee U, Lim C, Shaw-Saliba K, Menezes MJ, Mascarenhas A, Chery L, Gomes E, Rathod PK, Ferreira MU, Duraisingh MT. Enhanced ex vivo Plasmodium vivax intraerythrocytic enrichment and maturation for rapid and sensitive parasite growth assays [Internet]. Antimicrobial Agents and Chemotherapy. 2018 ; 62( 4): e02519-7.Available from: http://dx.doi.org/10.1128/AAC.02519-17
Vancouver
Rangel GW, Clark MA, Kanjee U, Lim C, Shaw-Saliba K, Menezes MJ, Mascarenhas A, Chery L, Gomes E, Rathod PK, Ferreira MU, Duraisingh MT. Enhanced ex vivo Plasmodium vivax intraerythrocytic enrichment and maturation for rapid and sensitive parasite growth assays [Internet]. Antimicrobial Agents and Chemotherapy. 2018 ; 62( 4): e02519-7.Available from: http://dx.doi.org/10.1128/AAC.02519-17
Artigo de periodico-carta/editorial
Coexistence of CTX-M-2, CTX-M-55, CMY-2, FosA3 and QnrB19 in extraintestinal pathogenic Escherichia coli from poultry in Brazil. [Letter] (2017)
Cunha, Marcos Paulo Vieira; Lincopan, Nilton; Cerdeira, Louise Teixeira; Esposito, Fernanda Ribeiro dos Santos; Dropa, Milena; Franco, Leticia S.; Moreno, Andrea Micke; Knöbl, Terezinha
Source: Antimicrobial Agents and Chemotherapy. Unidades: FSP, FMVZ, ICB
Subjects: AVES, ESCHERICHIA COLI, RESISTÊNCIA MICROBIANA ÀS DROGAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CUNHA, Marcos Paulo Vieira; LINCOPAN, Nilton; CERDEIRA, Louise Teixeira; et al. Coexistence of CTX-M-2, CTX-M-55, CMY-2, FosA3 and QnrB19 in extraintestinal pathogenic Escherichia coli from poultry in Brazil. [Letter]. Antimicrobial Agents and Chemotherapy[S.l: s.n.], 2017.Disponível em: DOI: 10.1128/AAC.02474-16.
APA
Cunha, M. P. V., Lincopan, N., Cerdeira, L. T., Esposito, F. R. dos S., Dropa, M., Franco, L. S., et al. (2017). Coexistence of CTX-M-2, CTX-M-55, CMY-2, FosA3 and QnrB19 in extraintestinal pathogenic Escherichia coli from poultry in Brazil. [Letter]. Antimicrobial Agents and Chemotherapy. Washington. doi:10.1128/AAC.02474-16
NLM
Cunha MPV, Lincopan N, Cerdeira LT, Esposito FR dos S, Dropa M, Franco LS, Moreno AM, Knöbl T. Coexistence of CTX-M-2, CTX-M-55, CMY-2, FosA3 and QnrB19 in extraintestinal pathogenic Escherichia coli from poultry in Brazil. [Letter] [Internet]. Antimicrobial Agents and Chemotherapy. 2017 ; 61( 4): 3 .Available from: http://dx.doi.org/10.1128/AAC.02474-16
Vancouver
Cunha MPV, Lincopan N, Cerdeira LT, Esposito FR dos S, Dropa M, Franco LS, Moreno AM, Knöbl T. Coexistence of CTX-M-2, CTX-M-55, CMY-2, FosA3 and QnrB19 in extraintestinal pathogenic Escherichia coli from poultry in Brazil. [Letter] [Internet]. Antimicrobial Agents and Chemotherapy. 2017 ; 61( 4): 3 .Available from: http://dx.doi.org/10.1128/AAC.02474-16
Artigo de periodico-carta/editorial
Complete DNA sequence of IncM1 plasmid bearing the novel qnrE1 PMQR variant and blaCTX-M-8 from Klebsiella pneumoniae ST147. [Letter] (2017)
Cunha, Marcos Paulo Vieira; Davies, Yamê Miniero; Cerdeira, Louise Teixeira; Dropa, Milena; Lincopan, Nilton; Knöbl, Terezinha
Source: Antimicrobial Agents and Chemotherapy. Unidades: ICB, FMVZ
Subjects: GENÉTICA BACTERIANA, PLASMÍDEOS, ENTEROBACTERIACEAE, SEQUÊNCIA DO DNA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CUNHA, Marcos Paulo Vieira; DAVIES, Yamê Miniero; CERDEIRA, Louise Teixeira; et al. Complete DNA sequence of IncM1 plasmid bearing the novel qnrE1 PMQR variant and blaCTX-M-8 from Klebsiella pneumoniae ST147. [Letter]. Antimicrobial Agents and Chemotherapy[S.l: s.n.], 2017.Disponível em: DOI: 10.1128/AAC.00592-17.
APA
Cunha, M. P. V., Davies, Y. M., Cerdeira, L. T., Dropa, M., Lincopan, N., & Knöbl, T. (2017). Complete DNA sequence of IncM1 plasmid bearing the novel qnrE1 PMQR variant and blaCTX-M-8 from Klebsiella pneumoniae ST147. [Letter]. Antimicrobial Agents and Chemotherapy. Washington. doi:10.1128/AAC.00592-17
NLM
Cunha MPV, Davies YM, Cerdeira LT, Dropa M, Lincopan N, Knöbl T. Complete DNA sequence of IncM1 plasmid bearing the novel qnrE1 PMQR variant and blaCTX-M-8 from Klebsiella pneumoniae ST147. [Letter] [Internet]. Antimicrobial Agents and Chemotherapy. 2017 ; 61( 9): 3 .Available from: http://dx.doi.org/10.1128/AAC.00592-17
Vancouver
Cunha MPV, Davies YM, Cerdeira LT, Dropa M, Lincopan N, Knöbl T. Complete DNA sequence of IncM1 plasmid bearing the novel qnrE1 PMQR variant and blaCTX-M-8 from Klebsiella pneumoniae ST147. [Letter] [Internet]. Antimicrobial Agents and Chemotherapy. 2017 ; 61( 9): 3 .Available from: http://dx.doi.org/10.1128/AAC.00592-17
Artigo de periodico
Efficacy of -Lactam/-Lactamase Inhibitor Combinations for the Treatment of Bloodstream Infection Due to Extended-Spectrum--LactamaseProducing Enterobacteriaceae in Hematological Patients with Neutropenia C (2017)
Gudiol, Carlota; Royo-Cebrecos, Cristina; Abdala, Edson; Akova, Murat; Álvarez, Rocío; Maestro-de la Calle,Guillermo; Cano, Angela; Cervera, Carlos; Clemente, Wanessa T.; Martin-Dávila, Pilar; Freifeld, Alison; Gómez, Lucia; Gottlieb, Thomas
Source: Antimicrobial Agents and Chemotherapy. Unidade: FM
Subjects: INFECÇÕES POR ENTEROBACTERIACEAE, INIBIDORES DE ENZIMAS, INFECÇÕES OPORTUNISTAS, DOENÇAS HEMATOLÓGICAS, SISTEMA IMUNE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GUDIOL, Carlota; ROYO-CEBRECOS, Cristina; ABDALA, Edson; et al. Efficacy of -Lactam/-Lactamase Inhibitor Combinations for the Treatment of Bloodstream Infection Due to Extended-Spectrum--LactamaseProducing Enterobacteriaceae in Hematological Patients with Neutropenia C. Antimicrobial Agents and Chemotherapy, Washington, v. 61, n. 8, 2017. Disponível em: < http://aac.asm.org/content/61/8/e00164-17 > DOI: 10.1128/AAC.00164-17.
APA
Gudiol, C., Royo-Cebrecos, C., Abdala, E., Akova, M., Álvarez, R., Maestro-de la Calle, G., et al. (2017). Efficacy of -Lactam/-Lactamase Inhibitor Combinations for the Treatment of Bloodstream Infection Due to Extended-Spectrum--LactamaseProducing Enterobacteriaceae in Hematological Patients with Neutropenia C. Antimicrobial Agents and Chemotherapy, 61( 8). doi:10.1128/AAC.00164-17
NLM
Gudiol C, Royo-Cebrecos C, Abdala E, Akova M, Álvarez R, Maestro-de la Calle G, Cano A, Cervera C, Clemente WT, Martin-Dávila P, Freifeld A, Gómez L, Gottlieb T. Efficacy of -Lactam/-Lactamase Inhibitor Combinations for the Treatment of Bloodstream Infection Due to Extended-Spectrum--LactamaseProducing Enterobacteriaceae in Hematological Patients with Neutropenia C [Internet]. Antimicrobial Agents and Chemotherapy. 2017 ; 61( 8):Available from: http://aac.asm.org/content/61/8/e00164-17
Vancouver
Gudiol C, Royo-Cebrecos C, Abdala E, Akova M, Álvarez R, Maestro-de la Calle G, Cano A, Cervera C, Clemente WT, Martin-Dávila P, Freifeld A, Gómez L, Gottlieb T. Efficacy of -Lactam/-Lactamase Inhibitor Combinations for the Treatment of Bloodstream Infection Due to Extended-Spectrum--LactamaseProducing Enterobacteriaceae in Hematological Patients with Neutropenia C [Internet]. Antimicrobial Agents and Chemotherapy. 2017 ; 61( 8):Available from: http://aac.asm.org/content/61/8/e00164-17

USP Schools

ReP

Filtros

USP Schools

Departament

Authors

USP affiliated authors

Date published

Subjects

Grupo de pesquisa

Funding Agencies

Normalized affiliation

Non normalized affiliation

Countries of institutions of collaboration

Keywords